HOME




Wednesday, 8 September 2010
Novogen agrees to sell its Intellectual Property Portfolio to its subsidiary Marshall Edwards

More news

 





Back Newsletter

Glycotex Newsletter (February, 2009)
Click to download(PDF)

Glycotex update to Shareholders.

Glycotex Newsletter (October 2008)
Click to download(PDF)

Glycotex update to Shareholders.

Novogen Newsletter (May, 2008)
Click to download(PDF)

Novogen Newsletter May, 2008.

Marshall Edwards' Newsletter (August 2007)
Click to download(PDF) Marshall Edwards’ Newsletter August, 2007.
Marshall Edwards’ Newsletter (December 2006)
Click to download(PDF) Marshall Edwards’ Newsletter.
Novogen Newsletter (May 2006)
Click to download(PDF) Novogen newsletter.
Novogen Newsletter (June 2004)
Click to download(PDF) Novogen makes further advances.
Novogen Newsletter (June 2003)
Click to download(PDF) Latest updates from Novogen.
Letter from the CEO (May 2002)
Click to download(PDF) Exciting advances within Novogen over the lastfew months.
R&D Review (July 2001)
Click to download(PDF) This edition of the Novogen newsletter is a review of the Company’s research and development.activities.
Phenolic Hormones (2000)
Click to download(PDF) • NV-06 in human anti-cancer trials• NV-04 program achieves major milestone• NV-07 shows early promise as an anti-inflammatory compound• Rimostil prepares for market launch• Promensil delivers important health benefits in clinical studies• Novogen moves up in Nasdaq
To view the newsletters, you will need to have Adobe Acrobat installed on your system.Click here to download Acrobat.
 
Top

 





About Novogen | Knowledge Base | Consumer Health | Pharmaceuticals | News | Investor Relations | Contact | Site Map
Copyright © 2010 Novogen The world leader in isoflavone research - with products including Promensil and Trinovin | Web Design by Newgency